We are live on ! Find out more
CCC

Chelsea Counsel Company Portfolio holdings

AUM $225M
1-Year Est. Return 45.99%
This Fund
S&P 500
This Quarter Est. Return
+1.01%
1 Year Est. Return
+45.99%
3 Year Est. Return
+94.6%
5 Year Est. Return
+122.61%
10 Year Est. Return
+380.48%
AUM
$227M
AUM Growth
-$3.99M
Cap. Flow
-$1.38M
Cap. Flow %
-0.61%
Top 10 Hldgs %
45.71%
Holding
108
New
11
Increased
10
Reduced
39
Closed
7

Top Buys

Rank Stock Value
1
RTN
Raytheon Company
RTN
+$3.15M
2
PYPL icon
PayPal
PYPL
+$1.53M
3
SHEL icon
Shell
SHEL
+$1.43M
4
XOM icon
ExxonMobil
XOM
+$941K
5
AEP icon
American Electric Power
AEP
+$883K

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$1.73M
2
PFE icon
Pfizer
PFE
+$1.34M
3
CMP icon
Compass Minerals
CMP
+$1.32M
4
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
+$1.17M
5
AAPL icon
Apple
AAPL
+$943K

Sector Composition

Rank Sector Weight
1 Technology 18.87%
2 Industrials 14.78%
3 Healthcare 14.49%
4 Communication Services 12.02%
5 Energy 8.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ECL icon
26
Ecolab
ECL
$79.8B
$2.44M 1.08%
13,825
-185
-1% -$34.8K
TRP icon
27
TC Energy
TRP
$66.3B
$2.34M 1.03%
41,400
– –
KMB icon
28
Kimberly-Clark
KMB
$36.1B
$2.19M 0.96%
17,745
– –
SHEL icon
29
Shell
SHEL
$250B
$1.94M 0.86%
+26,912
New +$1.43M
LDOS icon
30
Leidos
LDOS
$17.7B
$1.85M 0.82%
17,143
-250
-1% -$24.1K
NEE icon
31
NextEra Energy
NEE
$179B
$1.82M 0.8%
21,499
– –
NWL icon
32
Newell Brands
NWL
$2.62B
$1.81M 0.8%
84,523
-1,289
-2% -$29.8K
BIP icon
33
Brookfield Infrastructure Partners
BIP
$18.1B
$1.73M 0.76%
39,150
– –
GSK icon
34
GSK
GSK
$102B
$1.6M 0.7%
29,360
– –
BRK.A icon
35
Berkshire Hathaway Class A
BRK.A
$1.11T
$1.59M 0.7%
3
– –
ENB icon
36
Enbridge
ENB
$113B
$1.5M 0.66%
32,463
– –
AEM icon
37
Agnico Eagle Mines
AEM
$92B
$1.43M 0.63%
23,286
+1,019
+5% +$55.1K
T icon
38
AT&T
T
$168B
$1.43M 0.63%
79,925
– –
NTR icon
39
Nutrien
NTR
$32.1B
$1.42M 0.63%
13,690
-200
-1% -$16.6K
FNV icon
40
Franco-Nevada
FNV
$46.4B
$1.34M 0.59%
8,400
+100
+1% +$14.4K
NEM icon
41
Newmont
NEM
$124B
$1.19M 0.53%
15,004
+114
+0.8% +$7.71K
VTR icon
42
Ventas
VTR
$44.6B
$1.12M 0.5%
18,200
– –
BRK.B icon
43
Berkshire Hathaway Class B
BRK.B
$1.11T
$1.1M 0.49%
3,130
– –
MRNA icon
44
Moderna
MRNA
$24.2B
$1.1M 0.48%
6,380
-25
-0.4% -$4.21K
LMT icon
45
Lockheed Martin
LMT
$138B
$1.07M 0.47%
2,424
– –
DIS icon
46
Walt Disney
DIS
$179B
$1.06M 0.47%
7,711
+130
+2% +$18.8K
INTC icon
47
Intel
INTC
$493B
$1.04M 0.46%
20,927
-100
-0.5% -$4.96K
V icon
48
Visa
V
$677B
$965K 0.43%
4,352
– –
AEP icon
49
American Electric Power
AEP
$67.3B
$964K 0.42%
+9,660
New +$883K
WEC icon
50
WEC Energy
WEC
$34.8B
$866K 0.38%
8,679
– –
1
2
3 4

Similar funds

BAM
Ballast Asset Management Dallas, Texas $225M AUM 38.45% 1-Year Est. Return
SFC
SEG Family Corp Toronto $225M AUM 47.92% 1-Year Est. Return
TWA
Tandem Wealth Advisors Phoenix, Arizona $224M AUM 12.83% 1-Year Est. Return
CP
CPV Partners Stamford, Connecticut $224M AUM 77.2% 1-Year Est. Return
MCF
MKA Charitable Fund San Francisco, California $224M AUM 5.71% 1-Year Est. Return
LLWM
Life Line Wealth Management Beverly Hills, California $224M AUM 23.42% 1-Year Est. Return
AM
Aspect Management Palo Alto, California $224M AUM
RCM
Regency Capital Management Honolulu, Hawaii $224M AUM 26.03% 1-Year Est. Return

Chelsea Counsel Company's Q1 2022 Portfolio in Review

As of Q1 2022, Chelsea Counsel Company held 108 positions worth $227M, down 1.7% from $231M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Chelsea Counsel Company's Q1 2022 filing shows 11 new, 10 increased, 39 reduced and 7 closed positions. Its largest new stake was Raytheon Company: 31,811 shares worth $3.15M. The largest sale was Novartis, an estimated $1.73M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Industrials and Healthcare.

  • Chelsea Counsel Company's largest Q1 2022 buy was Raytheon Company: 31,811 shares worth $3.15M.
  • Chelsea Counsel Company added most to PayPal in Q1 2022, an estimated $1.53M increase.
  • Chelsea Counsel Company's biggest Q1 2022 reduction was Pfizer, cutting an estimated $1.34M.
  • Chelsea Counsel Company fully exited Novartis in Q1 2022, selling an estimated $1.73M.
  • Chelsea Counsel Company's ten largest holdings make up 46% of its $227M portfolio in Q1 2022.
  • Chelsea Counsel Company opened 11 new positions and closed 7 in Q1 2022.
  • Chelsea Counsel Company's portfolio value fell 1.7% quarter-over-quarter to $227M.

Based on Chelsea Counsel Company's 13F filing for Q1 2022, filed 24 May 2022.